Case Analysis: Chimanlal Jagjivandas Sheth v. State of Maharashtra
Case Details
Case name: Chimanlal Jagjivandas Sheth v. State of Maharashtra
Court: Supreme Court of India
Judges: Syed Jaffer Imam, N. Rajagopala Ayyangar, J.R. Mudholkar, Subba Rao J
Date of decision: 26 September 1962
Citation / citations: 1963 AIR 665; 1963 SCR Supl. (1) 344
Case number / petition number: Criminal Appeal No. 107 of 1961; Cr. A. No. 21 of 1961
Proceeding type: Criminal Appeal
Source court or forum: Supreme Court of India
Source Judgment: Read judgment
Factual and Procedural Background
Chimanlal Jagjivandas Sheth carried on business as Deepak Trading Corporation at Bulakhidas Building, Vithaldas Road, Bombay. On 27 December 1958 a Sub‑Inspector of Police, assisted by a Drug Inspector, raided the premises and seized large quantities of absorbent cotton wool, roller bandages, gauze and related articles. The seized samples were sent to the Government Analyst, who reported that only the lint met the prescribed standard of quality while the other articles were sub‑standard.
The appellant was prosecuted before the Presidency Magistrate, 16th Court, Bombay, under section 18 of the Drugs Act for manufacturing drugs that were not of standard quality. The magistrate acquitted him on the ground that the prosecution had failed to prove possession of the articles.
The Bombay High Court re‑examined the evidence, held that the articles were in the appellant’s possession, were manufactured by him and were below the statutory standard, convicted him and sentenced him to three months’ rigorous imprisonment and a fine of Rs 500 for each count.
The appellant filed Criminal Appeal No. 107 of 1961 before the Supreme Court of India, seeking to set aside the conviction and sentence, or alternatively to obtain a reduction of the punishment.
Issues, Contentions and Controversy
The Court was called upon to determine whether the seized articles – absorbent cotton wool, roller bandages and gauze – fell within the definition of “drug” in section 3(b) of the Drugs Act, and consequently whether the appellant could be convicted under section 18 for manufacturing sub‑standard drugs. The appellant contended that the articles were merely surgical dressings and not “drugs,” relying on a report of a high‑powered medical committee that asserted such dressings lay outside the Act’s purview. The State argued that the expression “substances” in the statutory definition encompassed the articles because they were used “for or in the treatment” of disease, and that the Government Analyst’s report established their sub‑standard quality. The precise controversy therefore centered on the construction of the term “drug” and the admissibility of the expert committee’s opinion in statutory interpretation.
Statutory Framework and Legal Principles
Section 3(b) of the Drugs Act, 1940 (as amended by the Drugs (Amendment) Act, 1955) defined a “drug” to include medicines for internal or external use and “such substances (other than food) intended to affect the structure or any function of the human body or intended to be used for the destruction of vermin or insects which cause disease.” Section 18 penalised the manufacturing of drugs that were not of standard quality. The Court applied a purposive construction test, examining the ordinary meaning of “substances” and the legislative intent to prevent the circulation of sub‑standard therapeutic aids, rather than relying on external expert opinions.
Court’s Reasoning and Application of Law
The Court held that the term “substances” in section 3(b) was to be understood in its ordinary sense as “things.” It observed that absorbent cotton wool, roller bandages and gauze were “substances” within that meaning. The Court then examined whether those substances were used “for or in the treatment” of disease. It found that the articles were sterilised or otherwise treated to become disinfectant and were employed as surgical dressings, which are essential aids in the treatment of surgical and other medical cases. Accordingly, the Court concluded that the items fell within the statutory definition of “drug.” The Court rejected the appellant’s reliance on the medical committee’s report, stating that expert opinion could not dictate the construction of a statutory provision. Having accepted the High Court’s findings on possession, manufacture and sub‑standard quality, the Court affirmed the conviction and the sentence imposed.
Final Relief and Conclusion
The Supreme Court dismissed the appeal, refused the appellant’s request for a reduction of the sentence, and upheld the conviction under section 18 of the Drugs Act. The three‑month rigorous imprisonment and the fine of Rs 500 per count were left undisturbed.